Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erdem Gurel"'
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 54, Iss 1, Pp 81-84 (2011)
Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment
Externí odkaz:
https://doaj.org/article/ac18f88ac354400dab68801cc5e4b338
Autor:
Ömer Uludağ, Erhan Çene, Erdem Gurel, Çiğdem Çetin, Murat Bektaş, Yasemin Yalçınkaya, Reyhan Diz-Küçükkaya, Ahmet Gül, Murat Inanç, Bahar Artim-Esen
Publikováno v:
Lupus. 31:433-442
Objective To identify the different clinical phenotypes of antiphospholipid syndrome (APS) by using cluster analysis and describe cumulative damage of disease clusters. Methods This retrospective study includes patients with APS (±systemic lupus ery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a60a6d1884c98b602b5e3b69c999ee
https://doi.org/10.1177/09612033221079781
https://doi.org/10.1177/09612033221079781
Autor:
Safak Mirioglu, Suzan Cinar, Omer Uludag, Erdem Gurel, Sibel Varelci, Yasemin Ozluk, Isin Kilicaslan, Yasemin Yalcinkaya, Halil Yazici, Ahmet Gul, Murat Inanc, Bahar Artim-Esen
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Galectin-9, interferon-inducible protein-10 (IP-10) and sialoadhesin (SIGLEC-1) are considered as potential biomarkers reflecting disease activity in patients with systemic lupus erythematosus (SLE). In this study, we aimed to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::940991a751d2c894a9ce0c9385b66f08
https://doi.org/10.1093/ndt/gfac110.003
https://doi.org/10.1093/ndt/gfac110.003
Autor:
Ozgur Akin Oto, Yasar Caliskan, Ahmet Burak Dirim, Irem Aktar, Erdem Gurel, Merve Guzel-Dirim, Asli Kara, Mehmet Sukru Sever, Safak Mirioglu, Aylin Ciftkaya, Halil Yazici, Isin Kilicaslan, Yasemin Ozluk, Aydin Turkmen
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Although hematuria is the cardinal symptom of IgA nephropathy (IgAN), its effects on the outcome have not been studied extensively. We, therefore, aimed to analyze the association between microhematuria and clinicopathological fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbf4daf928e4fc790e34817d8a30c50a
https://doi.org/10.1093/ndt/gfaa142.p0406
https://doi.org/10.1093/ndt/gfaa142.p0406
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 54, Iss 1, Pp 81-84 (2011)
Background Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21de78a70a708cfca129811d9f151d7b
http://www.ijpmonline.org/article.asp?issn=0377-4929
http://www.ijpmonline.org/article.asp?issn=0377-4929